All Stories

  1. Chromatin conformation capture in the clinic: 4C-seq/HiC distinguishes pathogenic from neutral duplications at the GPR101 locus

    Article • Genome Medicine, September 2024, Springer Science + Business Media

    Adrian Daly

  2. The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism

    Article • Endocrine Reviews, May 2024, Endocrine Society

    Adrian Daly

  3. Pituitary Acrogigantism: From the Past to the Future

    Article • January 2024, Karger Publishers

    Adrian Daly

  4. The Role of MCM9 in the Etiology of Sertoli Cell-Only Syndrome and Premature Ovarian Insufficiency

    Article • Journal of Clinical Medicine, January 2023, MDPI AG

    Adrian Daly

  5. Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion

    Article • January 2023, Cold Spring Harbor Laboratory Press

    Adrian Daly

  6. Bases moléculaires du gigantisme hypophysaire

    Article • Bulletin de l Académie Nationale de Médecine, August 2022, Elsevier

    Adrian Daly

  7. Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 Cases

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2022, Endocrine Society

    Adrian Daly

  8. Complicated Clinical Course in Incipient Gigantism Due to Treatment-resistant Aryl Hydrocarbon Receptor–Interacting Protein–mutated Pediatric Somatotropinoma

    Article • AACE Clinical Case Reports, May 2022, Elsevier

    Adrian Daly

  9. Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism

    Article • The American Journal of Human Genetics, April 2022, Elsevier

    Adrian Daly

  10. Comment on "Persistent remission of acromegaly in a patient with GH‐secreting pituitary adenoma: Effect of treatment with pasireotide long‐acting release and consequence of treatment withdrawal"

    Article • Journal of Clinical Pharmacy and Therapeutics, March 2022, Wiley

    Adrian Daly

  11. Dutch founder SDHB exon 3 deletion in patients with pheochromocytoma-paraganglioma in South Africa

    Article • Endocrine Connections, January 2022, Bioscientifica

    Adrian Daly

  12. Genetics of Pituitary Adenoma Syndromes

    Article • January 2022, Elsevier

    Adrian Daly

  13. A hard look at cardiac safety with dopamine agonists in endocrinology

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2021, Endocrine Society

    Adrian Daly

  14. Differentiated thyroid carcinoma in sporadic and familial presentations of acromegaly: A case series

    Article • Annales d Endocrinologie, October 2020, Elsevier

    Adrian Daly

  15. GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11

    Article • Nature Communications, September 2020, Springer Science + Business Media

    Adrian Daly

  16. miR ‐34a is upregulated in AIP ‐ mutated somatotropinomas and promotes octreotide resistance

    Article • International Journal of Cancer, September 2020, Wiley

    Adrian Daly

  17. The Epidemiology of Pituitary Adenomas

    Article • Endocrinology and Metabolism Clinics of North America, September 2020, Elsevier

    Adrian Daly

  18. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: GPR101, an orphan GPCR with roles in growth and pituitary tumorigenesis

    Article • Endocrine Related Cancer, August 2020, Bioscientifica

    Adrian Daly

  19. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA)

    Article • Endocrine Related Cancer, August 2020, Bioscientifica

    Adrian Daly

  20. Pituitary Disease in AIP Mutation-Positive Familial Isolated Pituitary Adenoma (FIPA): A Kindred-Based Overview

    Article • Journal of Clinical Medicine, June 2020, MDPI AG

    Adrian Daly

  21. Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2020, Endocrine Society

    Adrian Daly, DAVIDE CARVALHO

  22. Pancreatic Neuroendocrine Neoplasm Associated with a Familial MAX Deletion

    Article • Hormone and Metabolic Research, June 2020, Thieme Publishing Group

    Adrian Daly

  23. The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) study

    Article • Endocrine, April 2020, Springer Science + Business Media

    Adrian Daly

  24. Clinical and Molecular Update on Genetic Causes of Pituitary Adenomas

    Article • Hormone and Metabolic Research, April 2020, Thieme Publishing Group

    Adrian Daly

  25. Acromegaly in the setting of Tatton-Brown-Rahman Syndrome

    Article • Pituitary, December 2019, Springer Science + Business Media

    Adrian Daly

  26. Long-term remission of disseminated parathyroid cancer following immunotherapy

    Article • Endocrine, November 2019, Springer Science + Business Media

    Adrian Daly

  27. GENETICS IN ENDOCRINOLOGY: Somatic and germline mutations in the pathogenesis of pituitary adenomas

    Article • European Journal of Endocrinology, October 2019, Bioscientifica

    Adrian Daly

  28. Compound heterozygous mutations in the luteinizing hormone receptor signal peptide causing 46,XY disorder of sex development

    Article • European Journal of Endocrinology, August 2019, Bioscientifica

    Adrian Daly

  29. Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma

    Article • European Journal of Endocrinology, August 2019, Bioscientifica

    Adrian Daly

  30. Shrinkage of pituitary adenomas with pasireotide

    Article • The Lancet Diabetes & Endocrinology, July 2019, Elsevier

    Adrian Daly

  31. AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center

    Article • Endocrine Connections, April 2019, Bioscientifica

    Adrian Daly

  32. AIP-mutated acromegaly resistant to first-generation somatostatin analogs: long-term control with pasireotide LAR in two patients

    Article • Endocrine Connections, April 2019, Bioscientifica

    Adrian Daly

  33. Epidemiology and Management Challenges in Prolactinomas

    Article • Neuroendocrinology, February 2019, Karger Publishers

    Adrian Daly

  34. Genetic Testing in Pituitary Adenomas: What, How, and In Whom?

    Article • Endocrinología Diabetes y Nutrición, February 2019, Elsevier

    Adrian Daly

  35. The causes and consequences of pituitary gigantism

    Article • Nature Reviews Endocrinology, October 2018, Springer Science + Business Media

    Adrian Daly

  36. Resistant Paediatric Somatotropinomas due to AIP Mutations: Role of Pegvisomant

    Article • Hormone Research in Paediatrics, June 2018, Karger Publishers

    Adrian Daly

  37. Cellular effects of AP102, a somatostatin analog with balanced affinities for the hSSTR2 and hSSTR5 receptors

    Article • Neuropeptides, April 2018, Elsevier

    Adrian Daly

  38. MAX intragenic deletions occur in patients with pheochromocytoma and pituitary adenoma

    Article • Endocrine Related Cancer, March 2018, Bioscientifica

    Adrian Daly

  39. Effect of AP102, a subtype 2 and 5 specific somatostatin analog, on glucose metabolism in rats

    Article • Endocrine, August 2017, Springer Science + Business Media

    Adrian Daly

  40. Acromegaly characteristics at diagnosis: the largest study to date.

    Article • Endocrine Related Cancer, July 2017, Bioscientifica

    Adrian Daly, DAVIDE CARVALHO

  41. Adipsic diabetes insipidus revealing a bifocal intracranial germinoma

    Article • Annales d Endocrinologie, July 2017, Elsevier

    Adrian Daly

  42. AIP mutations and gigantism

    Article • Annales d Endocrinologie, June 2017, Elsevier

    Adrian Daly

  43. Overview of XLAG and how we discovered it

    Article • Annales d Endocrinologie, June 2017, Elsevier

    Adrian Daly

  44. Transdifferentiation of Neuroendocrine Cells

    Article • The American Journal of Surgical Pathology, June 2017, Wolters Kluwer Health

    Adrian Daly, Professor Gerald Raverot

  45. Elucidating the molecular mechanisms underlying AIP dependent tumorigenesis

    Article • Endocrine Abstracts, May 2017, Bioscientifica

    Adrian Daly

  46. GPR101 orphan receptor: a novel cause of growth hormone deregulation

    Article • Endocrine Abstracts, May 2017, Bioscientifica

    Adrian Daly

  47. Comment on “Hypogonadotrophic hypogonadism due to a mutation in the luteinizing hormone β-subunit gene”

    Article • The Korean Journal of Internal Medicine, May 2017, Korean Association of Internal Medicine (KAMJE)

    Adrian Daly

  48. Primary hypertrophic osteoarthropathy due to a novel SLCO2A1 mutation masquerading as acromegaly

    Article • Endocrinology Diabetes and Metabolism Case Reports, April 2017, Bioscientifica

    Adrian Daly

  49. A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues

    Article • European Journal of Endocrinology, January 2017, Bioscientifica

    Adrian Daly, DAVIDE CARVALHO

  50. New technology combined with a new disease used to explain an old case of gigantism

    Article • Endocrine Related Cancer, January 2017, Bioscientifica

    Adrian Daly

  51. Genetics of Pituitary Tumor Syndromes

    Article • January 2017, Elsevier

    Adrian Daly

  52. The role of AIP mutations in pituitary adenomas: 10 years on

    Article • Endocrine, December 2016, Springer Science + Business Media

    Adrian Daly

  53. Erratum to: Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia

    Article • Endocrine, November 2016, Springer Science + Business Media

    Adrian Daly

  54. Polymorphism or mutation? - The role of the R304Q missense AIP mutation in the predisposition to pituitary adenoma

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Marta Korbonits, Adrian Daly

  55. Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia

    Article • Endocrine, October 2016, Springer Science + Business Media

    Adrian Daly

  56. A region, common to all glycoprotein homones, essential for secretion

    Article • Journal of Endocrinology, September 2016, Bioscientifica

    Adrian Daly, Professor Adolfo Rivero-Muller

  57. T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly

    Article • Endocrine Related Cancer, September 2016, Bioscientifica

    Dr Irena Ilovayskaya, Adrian Daly, Professor Gerald Raverot

  58. Combined treatment with octreotide LAR and pegvisomant in patients with pituitary gigantism: clinical evaluation and genetic screening

    Article • Pituitary, June 2016, Springer Science + Business Media

    Adrian Daly

  59. Characterization ofGPR101transcript structure and expression patterns

    Article • Journal of Molecular Endocrinology, June 2016, Bioscientifica

    Adrian Daly

  60. Genetic predisposition to breast cancer occurring in a male-to-female transsexual patient

    Article • Endocrine Abstracts, May 2016, Bioscientifica

    Adrian Daly

  61. Combined treatment with octreotide LAR and pegvisomant in patients with gigantism - acromegaly: clinical evaluation and genetic screening

    Article • Endocrine Abstracts, May 2016, Bioscientifica

    Adrian Daly

  62. Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells

    Article • Molecular and Cellular Endocrinology, May 2016, Elsevier

    Adrian Daly

  63. MANAGEMENT OF ENDOCRINE DISEASE: Pituitary ‘incidentaloma’: neuroradiological assessment and differential diagnosis

    Article • European Journal of Endocrinology, April 2016, Bioscientifica

    Adrian Daly

  64. Genetic risk of breast cancer is important to consider in transexuals receiving hormone therapy

    Article • Endocrine Related Cancer, March 2016, Bioscientifica

    Adrian Daly

  65. Screening for GPR101 defects in pediatric pituitary corticotropinomas

    Article • Endocrine Related Cancer, March 2016, Bioscientifica

    Adrian Daly

  66. Mosaicism for X chromosome duplications including GPR101 cause X-LAG syndrome in sporadic males

    Article • Endocrine Related Cancer, March 2016, Bioscientifica

    Adrian Daly

  67. Gigantism, acromegaly and GPR101

    Article • Endocrine Abstracts, February 2016, Bioscientifica

    Adrian Daly

  68. Bifocal intracranial germinoma presenting as adipsic diabetes insipidus

    Article • Endocrine Abstracts, February 2016, Bioscientifica

    Adrian Daly

  69. Erratum to “Pituitary gigantism: Causes and clinical characteristics” [Ann. Endocrinol. (Paris) 76 (2015) 643–649]

    Article • Annales d Endocrinologie, February 2016, Elsevier

    Adrian Daly

  70. GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency

    Article • Hormone and Metabolic Research, January 2016, Thieme Publishing Group

    Adrian Daly

  71. Functioning Pituitary Adenomas

    Article • January 2016, Elsevier

    Adrian Daly, Dr Liliya Rostomyan

  72. List of Contributors

    Article • January 2016, Elsevier

    Adrian Daly, Dr Liliya Rostomyan

  73. Growth hormone releasing hormone is abnormally elevated in patients with X-linked acrogigantism

    Article • Endocrine Related Cancer, December 2015, Bioscientifica

    Adrian Daly

  74. Pituitary gigantism: Causes and clinical characteristics

    Article • Annales d Endocrinologie, December 2015, Elsevier

    Adrian Daly

  75. Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome

    Article • Endocrine, November 2015, Springer Science + Business Media

    Adrian Daly

  76. Étude moléculaire du gène AIP sur plus de 1400 individus atteints d’adénome hypophysaire

    Article • Annales d Endocrinologie, September 2015, Elsevier

    Adrian Daly, Dr Liliya Rostomyan

  77. Hyperparathyroïdie primaire familiale isolée – corrélation génotype-phénotype des mutations MEN1 ?

    Article • Annales d Endocrinologie, September 2015, Elsevier

    Adrian Daly

  78. Une forme compliquée d’hypercalcémie hypocalciurique familiale

    Article • Annales d Endocrinologie, September 2015, Elsevier

    Adrian Daly

  79. Causes and Characteristics of Pituitary Gigantism

    Article • Endocrine Related Cancer, July 2015, Bioscientifica

    Adrian Daly, Dr Liliya Rostomyan, Dr Irena Ilovayskaya

  80. Pancreatitis in familial hypocalciuric hypercalcaemia

    Article • Endocrine Abstracts, May 2015, Bioscientifica

    Adrian Daly

  81. Molecular analysis of miRNA expression profiles in AIP mutation positive somatotropinomas

    Article • Endocrine Abstracts, May 2015, Bioscientifica

    Adrian Daly

  82. Recurrence of GH-secreting pituitary adenomas during puberty in children with germline AIP mutations: a clinical challenge

    Article • Endocrine Abstracts, May 2015, Bioscientifica

    Adrian Daly

  83. Molecular and pathological determinants of somatostatin analogue resistance: somatotropinomas in AIP mutated and X-LAG syndrome patients

    Article • Endocrine Abstracts, May 2015, Bioscientifica

    Adrian Daly, Dr Liliya Rostomyan

  84. The genetic causes of pituitary gigantism

    Article • Endocrine Abstracts, May 2015, Bioscientifica

    Adrian Daly, Dr Liliya Rostomyan

  85. The clinical characteristics of X-linked acro-gigantism syndrome

    Article • Endocrine Abstracts, May 2015, Bioscientifica

    Adrian Daly, Dr Liliya Rostomyan

  86. X-linked acro-gigantism (X-LAG): a new form of infant-onset pituitary gigantism

    Article • Endocrine Abstracts, May 2015, Bioscientifica

    Adrian Daly, Dr Liliya Rostomyan

  87. Gigantism, Acromegaly, and GPR101 Mutations

    Article • New England Journal of Medicine, March 2015, New England Journal of Medicine (NEJM/MMS)

    Adrian Daly

  88. A novel inactivating mutation of the LH/chorionic gonadotrophin receptor with impaired membrane trafficking leading to Leydig cell hypoplasia type 1

    Article • European Journal of Endocrinology, March 2015, Bioscientifica

    Adrian Daly, Professor Adolfo Rivero-Muller

  89. Familial Isolated Pituitary Adenomas (FIPA) and Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene

    Article • Endocrinology and Metabolism Clinics of North America, March 2015, Elsevier

    Adrian Daly

  90. X-linked acrogigantism syndrome: clinical profile and therapeutic responses

    Article • February 2015, Bioscientifica

    Adrian Daly, Dr Liliya Rostomyan

  91. Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences

    Article • January 2015, Bioscientifica

    Professor Gerald Raverot, Adrian Daly

  92. Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation

    Article • New England Journal of Medicine, December 2014, New England Journal of Medicine (NEJM/MMS)

    Adrian Daly, Dr Liliya Rostomyan

  93. McCune-Albright Syndrome: A Detailed Pathological and Genetic Analysis of Disease Effects in an Adult Patient

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2014, Endocrine Society

    Adrian Daly, Dr Liliya Rostomyan

  94. Le cancer thyroïdien papillaire familial (FNMTC) : études cliniques et génétiques chez 8 familles

    Article • Annales d Endocrinologie, October 2014, Elsevier

    Adrian Daly

  95. Intérêt du signal T2 des adénomes hypophysaires à GH traités par analogues de la somatostatine – premiers résultats de l’étude IRMA#2

    Article • Annales d Endocrinologie, October 2014, Elsevier

    Adrian Daly, Dr Liliya Rostomyan

  96. Challenges and controversies in the treatment of prolactinomas

    Article • Expert Review of Endocrinology & Metabolism, September 2014, Taylor & Francis

    Adrian Daly

  97. A clinically novel AIP mutation in a patient with a very large, apparently sporadic somatotrope adenoma

    Article • Endocrinology Diabetes and Metabolism Case Reports, August 2014, Bioscientifica

    Adrian Daly

  98. A bittersweet symphony

    Article • Endocrine Related Cancer, June 2014, Bioscientifica

    Adrian Daly

  99. Surgical management of pituitary adenomas

    Article • March 2014, Taylor & Francis

    Adrian Daly

  100. The Third/Second Generation PTH Assay Ratio as a Marker for Parathyroid Carcinoma: Evaluation Using an Automated Platform

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2014, Endocrine Society

    Adrian Daly, Prof Etienne Cavalier

  101. Deletion of exons 1–3 of the MEN1 gene in a large Italian family causes the loss of menin expression

    Article • Familial Cancer, February 2014, Springer Science + Business Media

    Adrian Daly

  102. Coexistence entre adénome hypophysaire et phéochromocytome – présentation de cas

    Article • Annales d Endocrinologie, September 2013, Elsevier

    Adrian Daly, Dr Liliya Rostomyan

  103. FIPA : étude clinique et génétique à l’Hôpital « King Edward Memorial », Bombay (Mumbai), Inde

    Article • Annales d Endocrinologie, September 2013, Elsevier

    Adrian Daly, Dr Liliya Rostomyan

  104. Le Gigantisme : les résultats d’une étude clinique et génétique internationale

    Article • Annales d Endocrinologie, September 2013, Elsevier

    Adrian Daly, Dr Liliya Rostomyan

  105. Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations

    Article • August 2013, Bioscientifica

    Adrian Daly, Dr Liliya Rostomyan

  106. Faculty Opinions recommendation of Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma/paraganglioma.

    Article • May 2013, F1000Research

    Adrian Daly

  107. Receptor expression in craniopharyngiomas causing tumor growth in pregnancy: case report and review of the literature

    Article • Endocrine Abstracts, April 2013, Bioscientifica

    Adrian Daly

  108. Characteristics of patients with pituitary gigantism: results of an international study

    Article • Endocrine Abstracts, April 2013, Bioscientifica

    Adrian Daly, Dr Irena Ilovayskaya, Dr Liliya Rostomyan

  109. Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene

    Article • Endocrine Reviews, April 2013, Endocrine Society

    Adrian Daly, Auli Karhu

  110. Young patients with pituitary adenomas should be assessed for MEN1 and AIP mutations

    Article • January 2013, Bioscientifica

    Adrian Daly

  111. Familial Pituitary Adenomas: An Overview

    Article • November 2012, Springer Science + Business Media

    Adrian Daly

  112. Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients

    Article • November 2012

    Adrian Daly

  113. Faculty Opinions recommendation of Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues.

    Article • October 2012, F1000Research

    Adrian Daly

  114. Faculty Opinions recommendation of Should aip gene screening be recommended in family members of FIPA patients with R16H variant?

    Article • September 2012, F1000Research

    Adrian Daly

  115. A study of the characteristics of cabergoline-resistant prolactinomas

    Article • August 2012, Bioscientifica

    Adrian Daly

  116. The Liege Acromegaly Survey (LAS): A new software tool for the study of acromegaly

    Article • Annales d Endocrinologie, June 2012, Elsevier

    Adrian Daly

  117. Clinical and genetic aspects of familial isolated pituitary adenomas

    Article • Clinics, April 2012, Fundacao Faculdade de Medicina

    Adrian Daly

  118. Faculty Opinions recommendation of The endemic paraganglioma syndrome type 1: origin, spread, and clinical expression.

    Article • April 2012, F1000Research

    Adrian Daly

  119. Overview of genetic testing in patients with pituitary adenomas

    Article • Annales d Endocrinologie, April 2012, Elsevier

    Adrian Daly, Dr Liliya Rostomyan

  120. Clinical characterization of cabergoline resistant prolactinomas: A multicenter experience on 92 patients

    Article • Annales d Endocrinologie, April 2012, Elsevier

    Adrian Daly

  121. A prospective study of cardiac valvular status in patients treated with cabergoline for endocrine disease

    Article • Annales d Endocrinologie, April 2012, Elsevier

    Adrian Daly, Dr Julien Magne

  122. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds

    Article • January 2012, Bioscientifica

    Adrian Daly

  123. Faculty Opinions recommendation of Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype.

    Article • December 2011, F1000Research

    Adrian Daly

  124. Faculty Opinions recommendation of Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain.

    Article • November 2011, F1000Research

    Adrian Daly

  125. 36. A Tall Man with Hypogonadism

    Article • September 2011, Endocrine Society

    Adrian Daly

  126. High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas

    Article • July 2011

    Adrian Daly

  127. Familial Pituitary Tumor Syndromes

    Article • Endocrine Practice, July 2011, AACE Corp (American Association of Clinical Endocrinologists)

    Adrian Daly

  128. What to do with a pituitary incidentaloma?

    Article • Expert Review of Endocrinology & Metabolism, July 2011, Taylor & Francis

    Adrian Daly

  129. A Novel AIP Mutation Related to Familial Isolated Pituitary Adenomas (FIPA)

    Article • June 2011, Endocrine Society

    Adrian Daly

  130. Strategies for Screening and Management of Familial Isolated Pituitary Adenomas (FIPA): Our Experience on 17 Families in a Single Center in Brazil

    Article • June 2011, Endocrine Society

    Adrian Daly

  131. Impact of Germline AIP Mutations on Tumor Characteristics and Management in Young Acromegalic Patients: Results of an Age- and Tumor-Diameter-Matched Cohort Study

    Article • June 2011, Endocrine Society

    Adrian Daly

  132. Mutations of calcium-sensing receptor gene: two novel mutations and overview of impact on calcium homeostasis

    Article • European Journal of Endocrinology, May 2011, Bioscientifica

    Adrian Daly

  133. Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation

    Article • March 2011

    Adrian Daly

  134. Resistant prolactinomas

    Article • Journal of Endocrinological Investigation, March 2011, Springer Science + Business Media

    Adrian Daly

  135. Genetic susceptibility in pituitary adenomas: from pathogenesis to clinical implications

    Article • Expert Review of Endocrinology & Metabolism, March 2011, Taylor & Francis

    Adrian Daly

  136. Genetic Causes of Familial Pituitary Adenomas

    Article • January 2011, Springer Science + Business Media

    Adrian Daly

  137. Familial pituitary adenomas

    Article • Annales d Endocrinologie, December 2010, Elsevier

    Adrian Daly

  138. Aggressive prolactinoma in a child related to germline mutation in the ARYL hydrocarbon receptor interacting protein (AIP) gene

    Article • Arquivos Brasileiros de Endocrinologia & Metabologia, November 2010, FapUNIFESP (SciELO)

    Adrian Daly

  139. Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2010, Endocrine Society

    Professor Gerald Raverot, Adrian Daly

  140. The Ratio of Parathyroid Hormone as Measured by Third- and Second-Generation Assays as a Marker for Parathyroid Carcinoma

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2010, Endocrine Society

    Adrian Daly

  141. Management of acromegaly

    Article • F1000 Medicine Reports, July 2010, F1000Research

    Adrian Daly

  142. The genetics of pituitary adenomas

    Article • Best Practice & Research Clinical Endocrinology & Metabolism, June 2010, Elsevier

    Adrian Daly

  143. Hyperplasia-Adenoma Sequence in Pituitary Tumorigenesis Related to AIP Mutation.

    Article • June 2010, Endocrine Society

    Adrian Daly

  144. Prevalence of double pituitary adenomas in a surgical series: Clinical, histological and genetic features

    Article • Journal of Endocrinological Investigation, May 2010, Springer Science + Business Media

    Adrian Daly

  145. The role of germlineAIP,MEN1, PRKAR1A,CDKN1BandCDKN2Cmutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes

    Article • Clinical Genetics, February 2010, Wiley

    Adrian Daly

  146. Functioning Pituitary Adenomas

    Article • January 2010, Elsevier

    Adrian Daly

  147. Genetics of Cushing’s Syndrome

    Article • Neuroendocrinology, January 2010, Karger Publishers

    Adrian Daly

  148. Contributors

    Article • January 2010, Elsevier

    Adrian Daly

  149. Genetic Factors in the Development of Pituitary Adenomas

    Article • November 2009, Karger Publishers

    Adrian Daly

  150. Pituitary adenomas in young patients: when should we consider a genetic predisposition?

    Article • Expert Review of Endocrinology & Metabolism, November 2009, Taylor & Francis

    Adrian Daly

  151. The epidemiology and genetics of pituitary adenomas

    Article • Best Practice & Research Clinical Endocrinology & Metabolism, October 2009, Elsevier

    Adrian Daly

  152. De la génétique des adénomes hypophysaires familiaux

    Article • Bulletin de l Académie Nationale de Médecine, October 2009, Elsevier

    Adrian Daly

  153. Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP gene

    Article • European Journal of Endocrinology, August 2009, Bioscientifica

    Adrian Daly

  154. Mutaciones de AIP en adenomas hipofisarios familiares y esporádicos: experiencia local y revisión de la literatura

    Article • Endocrinología y Nutrición, August 2009, Elsevier

    Adrian Daly

  155. Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly

    Article • International Journal of Cancer, July 2009, Wiley

    Adrian Daly

  156. Familial pituitary adenomas

    Article • Journal of Internal Medicine, July 2009, Wiley

    Adrian Daly

  157. Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications

    Article • June 2009, Bioscientifica

    Adrian Daly

  158. Genetic, Molecular and Clinical Features of Familial Isolated Pituitary Adenomas

    Article • Hormone Research in Paediatrics, January 2009, Karger Publishers

    Adrian Daly

  159. Adénomes hypophysaires familiaux

    Article • La Presse Médicale, January 2009, Elsevier

    Adrian Daly

  160. Update on Familial Pituitary Tumors: from Multiple Endocrine Neoplasia Type 1 to Familial Isolated Pituitary Adenoma

    Article • Hormone Research in Paediatrics, January 2009, Karger Publishers

    Adrian Daly

  161. Testicular Effects of Isolated Luteinizing Hormone Deficiency and Reversal by Long-Term Human Chorionic Gonadotropin Treatment

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2009, Endocrine Society

    Adrian Daly

  162. Central Nervous System-Acting Drugs Influencing Hypothalamic-Pituitary-Adrenal Axis Function

    Article • January 2009, Karger Publishers

    Adrian Daly

  163. UPDATE ON THE TREATMENT OF PITUITARY ADENOMAS: FAMILIAL AND GENETIC CONSIDERATIONS

    Article • Acta Clinica Belgica, December 2008, Taylor & Francis

    Adrian Daly

  164. Toll‐like receptor‐4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxel

    Article • International Journal of Cancer, August 2008, Wiley

    Adrian Daly

  165. Cabergoline and the risk of valvular lesions in endocrine disease.

    Article • European Journal of Endocrinology, May 2008, Bioscientifica

    Adrian Daly

  166. Absence of hypogonadism in a male patient with a giant prolactinoma: A clinical paradox

    Article • Annales d Endocrinologie, February 2008, Elsevier

    Adrian Daly

  167. Current and future perspectives on recombinant growth hormone for the treatment of obesity

    Article • Expert Review of Endocrinology & Metabolism, January 2008, Taylor & Francis

    Adrian Daly

  168. Pseudomalabsorption of thyroid hormones: case report and review of the literature

    Article • Annales d Endocrinologie, December 2007, Elsevier

    Adrian Daly

  169. Characteristics of familial isolated pituitary adenomas

    Article • Expert Review of Endocrinology & Metabolism, November 2007, Taylor & Francis

    Adrian Daly

  170. Vitex agnus castus might enrich the pharmacological armamentarium for medical treatment of prolactinoma

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, November 2007, Elsevier

    Adrian Daly

  171. The clinical, pathological, and genetic features of familial isolated pituitary adenomas

    Article • European Journal of Endocrinology, October 2007, Bioscientifica

    Adrian Daly

  172. Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene

    Article • October 2007

    Adrian Daly

  173. Mutations in theAryl Hydrocarbon Receptor Interacting ProteinGene Are Not Highly Prevalent among Subjects with Sporadic Pituitary Adenomas

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2007, Endocrine Society

    Adrian Daly

  174. Aryl Hydrocarbon Receptor-Interacting Protein Gene Mutations in Familial Isolated Pituitary Adenomas: Analysis in 73 Families

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2007, Endocrine Society

    Professor Gerald Raverot, Adrian Daly

  175. The Epidemiology and Management of Pituitary Incidentalomas

    Article • Hormone Research in Paediatrics, January 2007, Karger Publishers

    Adrian Daly

  176. High Prevalence of Pituitary Adenomas: A Cross-Sectional Study in the Province of Liège, Belgium

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2006, Endocrine Society

    Adrian Daly

  177. P1-046 - The liege acromegaly survey

    Article • Annales d Endocrinologie, October 2006, Elsevier

    Adrian Daly

  178. CO05 - Identification d’une famille porteuse d’une nouvelle mutation bêta-LH accompagnée d’hypogonadisme

    Article • Annales d Endocrinologie, October 2006, Elsevier

    Adrian Daly

  179. P2-085 - Endocrine abnormalities in MC Cune-Albright syndrome

    Article • Annales d Endocrinologie, October 2006, Elsevier

    Adrian Daly

  180. P1-044 - Les patients acromégales sont-ils mal pris en charge ? de la mauvaise utilisation des bases de données

    Article • Annales d Endocrinologie, October 2006, Elsevier

    Adrian Daly

  181. The original clinical description of familial isolated pituitary adenomas (FIPA)

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2006, Endocrine Society

    Adrian Daly

  182. Serum levels of soluble CD163 correlate with the inflammatory process in coeliac disease

    Article • Alimentary Pharmacology & Therapeutics, August 2006, Wiley

    Adrian Daly

  183. Desloratadine for allergic rhinitis

    Article • Expert Review of Clinical Immunology, March 2006, Taylor & Francis

    Adrian Daly

  184. Diagnostic characteristics and therapeutic responses in acromegaly: The liege acromegaly survey

    Article • Experimental and Clinical Endocrinology & Diabetes, February 2006, Thieme Publishing Group

    Adrian Daly

  185. Does the nadir growth-hormone level predict response to somatostatin-analogue therapy?

    Article • Nature Clinical Practice Endocrinology &#38 Metabolism, January 2006, Springer Science + Business Media

    Adrian Daly

  186. Somatostatin Analogs in the Gastrointestinal Tract

    Article • January 2006, Elsevier

    Adrian Daly

  187. Predictors and rates of treatment-resistant tumor growth in acromegaly

    Article • August 2005

    Adrian Daly

  188. Acromegaly

    Article • June 2005, Taylor & Francis

    Adrian Daly

  189. Clinical and Genetic Features of Familial Pituitary Adenomas

    Article • Hormone and Metabolic Research, June 2005, Thieme Publishing Group

    Adrian Daly

  190. Treatment of Pituitary Tumors: Somatostatin

    Article • Endocrine, January 2005, Springer Science + Business Media

    Adrian Daly

  191. The Epidemiology of Prolactinomas

    Article • Pituitary, January 2005, Springer Science + Business Media

    Adrian Daly

  192. Cytokine Dysregulation, Inflammation and Well-Being

    Article • NeuroImmunoModulation, January 2005, Karger Publishers

    Adrian Daly

  193. Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs

    Article • European Journal of Endocrinology, January 2005, Bioscientifica

    Adrian Daly

  194. Desloratadine prevents compound 48/80-induced mast cell degranulation: visualization using a vital fluorescent dye technique

    Article • Allergy, January 2005, Wiley

    Adrian Daly

  195. Hypogonadism in a Patient with a Mutation in the Luteinizing Hormone Beta-Subunit Gene

    Article • New England Journal of Medicine, December 2004, New England Journal of Medicine (NEJM/MMS)

    Adrian Daly

  196. P018 - Une approche de la vraie prévalence des tumeurs hypophysaires

    Article • Annales d Endocrinologie, September 2004, Elsevier

    Adrian Daly

  197. CO10 - La réduction chirurgicale de la masse tumorale des adenomas hypophysaires améliore le contrôle médical de l’acromégalie par les analogues de la somatostatine

    Article • Annales d Endocrinologie, September 2004, Elsevier

    Adrian Daly

  198. Oral vitamin C reduces the injury to skeletal muscle caused by compartment syndrome

    Article • Journal of Bone and Joint Surgery - British Volume, August 2004, Bone & Joint

    Adrian Daly

  199. Hormonal and Biochemical Normalization and Tumor Shrinkage Induced by Anti-Parathyroid Hormone Immunotherapy in a Patient with Metastatic Parathyroid Carcinoma

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2004, Endocrine Society

    Adrian Daly

  200. Lanreotide Autogel?? for Acromegaly

    Article • Treatments in Endocrinology, January 2004, Springer Science + Business Media

    Adrian Daly

  201. Gonadotropin-Secreting Tumors

    Article • January 2004, Elsevier

    Adrian Daly

  202. Oral vitamin C attenuates acute ischaemia-reperfusion injury in skeletal muscle

    Article • Journal of Bone and Joint Surgery - British Volume, November 2001, Bone & Joint

    Adrian Daly

  203. Alcoholic ketoacidosis presenting as diabetic ketoacidosis

    Article • Irish Journal of Medical Science (1971 -), April 1999, Springer Science + Business Media

    Adrian Daly

  204. Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines☆☆☆★

    Article • Journal of Allergy and Clinical Immunology, February 1997, Elsevier

    Adrian Daly

  205. Pathologie inflammatoire de ľhypophyse et grossesse

    Article • Springer Science + Business Media

    Adrian Daly